Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis
4 affiliations
- 1Interdisciplinary Research Center for Brain-Computer Interface, Key Laboratory of Bioresource Research and Development of Liaoning Province, College of Life and Health Sciences, Northeastern University, Shenyang 110819, China
- 2National Frontiers Science Center for Industrial Intelligence and Systems Optimization, Northeastern University, Shenyang 110819, China
- 3Key Laboratory of Data Analytics and Optimization for Smart Industry, Northeastern University, Ministry of Education, Shenyang 110819, China
- 4School of Science, Liaodong University, Dandong 118003, China
Abstract
Adipocyte differentiation is central to adipose-tissue homeostasis, but its regulatory landscape remains incompletely defined in human cells. Here, we perform a genome-wide CRISPR/Cas9 knockout screen in oleic acid-differentiated human SW872 preadipocytes to identify functional regulators of white adipogenesis. The screens nominate hundreds of adipogenesis-regulating genes, and integration with human genetic evidence prioritizes nicotinate phosphoribosyltransferase (NAPRT) as a prominent player. NAPRT loss increases lipid accumulation and PPARγ abundance, reduces intracellular nicotinamide adenine dinucleotide (NAD+), and diminishes cytosolic β-catenin. Supplementation with nicotinamide mononucleotide restored NAD+ and partially reversed the signaling and adipogenic phenotypes, linking NAPRT-dependent NAD+ biosynthesis to WNT/β-catenin activity. Finally, deep learning-guided virtual screening nominates quinacrine as a candidate NAPRT inhibitor, and a lysate-based thermal shift assay shows quinacrine-dependent destabilization of NAPRT. These findings identify NAPRT as a metabolic regulator of human adipogenesis and connect NAD+ availability to WNT-dependent adipocyte fate control.
Related
- A genome-wide CRISPR knockout screen identifies host dependency factors and potential viral-induced cell death regulators for porcine deltacoronavirus infection
- Dual‐line Genome‐scale CRISPR Screening Enables Robust Target Gene Discovery
- Genome-wide CRISPR screening reveals a chromatin-to-mitochondrial dependency architecture underlying Galunisertib-induced OXPHOS vulnerability
- Suspension-Based Intracellular Immunofluorescence Staining Coupled With Genome-Wide CRISPR-Cas9 Screening to Identify Regulators of O-GlcNAcylation
- Spatiotemporal Mapping of Glomerular Endothelial Regeneration Identifies Apold1 as an Intrinsic Regulator of Repair
BibTeX
@article{liang2026genomewide,
title = {{Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis}},
author = {Ruipu Liang and Shuangshuang Fan and Shuwen Ma and Wenqing Ma and Zhuo Zuo and Chunge Zhong and Teng Fei},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms272210216},
url = {https://www.mdpi.com/1422-0067/27/22/10216},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genome-Wide CRISPR Screening Identifies NAPRT as a Key Regulator of Human Adipogenesis
AU - Ruipu Liang
AU - Shuangshuang Fan
AU - Shuwen Ma
AU - Wenqing Ma
AU - Zhuo Zuo
AU - Chunge Zhong
AU - Teng Fei
PY - 2026
DA - 2026/11/14
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms272210216
UR - https://www.mdpi.com/1422-0067/27/22/10216
AB - Adipocyte differentiation is central to adipose-tissue homeostasis, but its regulatory landscape remains incompletely defined in human cells. Here, we perform a genome-wide CRISPR/Cas9 knockout screen in oleic acid-differentiated human SW872 preadipocytes to identify functional regulators of white adipogenesis. The screens nominate hundreds of adipogenesis-regulating genes, and integration with human genetic evidence prioritizes nicotinate phosphoribosyltransferase (NAPRT) as a prominent player. NAPRT loss increases lipid accumulation and PPARγ abundance, reduces intracellular nicotinamide adenine dinucleotide (NAD+), and diminishes cytosolic β-catenin. Supplementation with nicotinamide mononucleotide restored NAD+ and partially reversed the signaling and adipogenic phenotypes, linking NAPRT-dependent NAD+ biosynthesis to WNT/β-catenin activity. Finally, deep learning-guided virtual screening nominates quinacrine as a candidate NAPRT inhibitor, and a lysate-based thermal shift assay shows quinacrine-dependent destabilization of NAPRT. These findings identify NAPRT as a metabolic regulator of human adipogenesis and connect NAD+ availability to WNT-dependent adipocyte fate control.
SN - 1422-0067
ER -